chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pains started on 5/5/21 around 4pm and worsened through 9pm.  The next morning chest pains continued to the point where I went to the Emergency Room.  There, a cardio ultrasound, blood work and a cardio catheter were performed.  Tests for all respiratory viruses all came back negative.  I was taken to the Critical Care Unit and remained under supervision overnight and through the morning  5/7/201, when I was discharged.  I was diagnosed with Myocarditis and Pericarditis.
Myalgia, Fever, CoughWheeze, Pain at injection site, sore throat, sweating Narrative:
Received MMR 4-4-08.  4-17-08 developed generalized rash, fever, body aches.
PCR testing which was positive for strain found in MMR II; had fever; rash; This spontaneous report was received from the employee from the office and refers to two 1-year-old female patients. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)(dose, frequency, route of administration, lot# and expiry date were not specified) for prophylaxis. Other suspect therapies included sterile diluent (Merck Sharp & Dohme). On unknown dates (also reported as "two of the patients were female and one of the patients was male", "4, 6 and 12 days respectively, after measles, mumps, and rubella (wistar ra 27-3; virus vaccine, live (M-M-R II) was administered"), the patients experienced fever and rash. Additionally, on unknown dates, the patients had polymerase chain reaction (PCR) testing which was positive for strain found in measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II).The outcome of the events was reported as recovered on an unknown date. The relatedness between the events and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA002031:
Large red rash covering upper arm at injection site, fever 101, body aches and headache
pt recvd vax & 3 days later devel purpura & a low platelet count; dx idiopathic thrombocytopenic purpura was made, pt was starte on Pred therapy; sx persist to the date of this report despite steroid therapy;
Patient had significant swelling to her right upper arm with hours after her injection.  No redness, warmth, fever, chills, or any other signs of infection noted.  Patient was instructed to use ice to area and benadryl as needed
ACUTE PULMONARY EMBOLISM 5/2/2023 BPH W LOWER URINARY TRACT SYMPTOMS ACUTE PULMONARY EMBOLISM 5/2/2023 HX OF ALCOHOL USE DISORDER ACUTE PULMONARY EMBOLISM 5/2/2023 ATRIAL FIBRILLATION, UNSPECIFIED    BRADYCARDIA
Pt developed swelling, pain - Nec. fasciitis - "possibly vaccine related". Reported at request of Public Health dept.
a positive Covid test after receiving their first dose; a positive Covid test after receiving their first dose; The initial case was missing the following minimum criteria: No adverse effect. Upon receipt of follow-up information on 06Jan2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable other healthcare professional (student pharmacist) and a contactable pharmacist reported that a patient of unspecified age and gender received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration, on an unspecified date, at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Reporter that works at a hospital pharmacy called about a patient that received their first dosage of COVID-19 vaccine who had a positive COVID test on an unspecified date after receiving their first dose of the vaccine. They wanted to know hoe to proceed and if they needed the second dose. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report has been received from a currently 75 year old female patient regarding herself. Patient's medical history included shingles, that started when was 62 years old. Shingles was diagnosed in approximately 2009 (2-3 years before patient was vaccinated with ZOSTAVAX in 2012). Other historical conditions included swollen eyes. Patient was not sleeping well at night and had to go through 7 years of the most horrifying experience with doctors, and a psychiatrist who tried to put  her on something that would have killed her or put her in a coma. The patient took antibiotics for 10 years that totally destroyed her immune system. Three years ago, in approximately 2012, patient was vaccinated with ZOSTAVAX (strength, dose and route of administration were not reported). The patient reported that she had shingles at the time of the shot. Concomitant medications included about 12 different supplements and monolaurin coconut oil but no prescription drugs. After receiving ZOSTAVAX, that patient still had shingles (vaccination failure). When she would get stressed out, it would flare up or get a lot worse. She had been to 7 dermatologists and 2 general practitioners who thought she had an intestinal problem (gastrointestinal disorder) and had her get 3 colonoscopies. On 27-JUN-2015, the patient reported that her shingles was terrible, which it was every other day. Her shingles was so painful that when she got in the shower, she would stand there screaming and crying like her skin was on fire (skin burning sensation). On the night of 27-JUN-2015, she got a good night's sleep. As of 28-JUN-2015, the shingles was better. On unknown dates, she had all kinds of lab work and blood tests that came back negative (normal). As of 28-JUN-2015, it was unknown if the therapy with ZOSTAVAX was continued. The outcome of gastrointestinal disorder, vaccination failure and skin burning sensation was unknown. The outcome of shingles, poor quality sleep and pain was reported as recovering/resolving. Causality assessment was not provided. Additional information is not expected since the reporter declined physician contact.
Bilateral lower thigh soreness starting 2 days after vaccine (12/21/20) subsequently developing into severe bilateral lower thigh pain and cramping 3 days after the vaccine (12/22/20) persisting for approximately 2 weeks. Confirmed as rhabdomyolysis with elevated CK on 12/29/20, and saw physician on 1/2/21, with subsequent downtrending CK but elevated on 1/2/21.
Pt was inadvertently given a Pfizer monovalent dose as a booster when this patient should have received a bivalent booster.
Fatigue - 2 days Soreness - 5 days Rash and itchiness - day 7  up to today which is day 12.
Dementia has increased.; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration first dose on 08Jan2021 at single dose for Covid-19 immunization. The patient's medical history included Covid and ongoing dementia. The patient's concomitant medications were not reported.  It was reported that patient had the vaccine on 08Jan2021. Less than a month after patient had Covid and was aware of the 90 day waiting time during positive Covid. It was also reported that patient experienced dementia had increased. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Generalized body rash, diagnosed on 11/17 by dermatologist as erythema multiforme. Rash appeared on back approximately 24 hours after vaccination and spread to entire body, persisting as of this writing (11/19). Rash is flat and itchy. Also experienced low grade fever and muscle aches that began overnight and  subsided within 24 hours of vaccination.
pt devel febrile react (fever to 103) w/in 24 hrs of receiving vax;
19 patients received an expired booster; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was monitored for at least 15 minutes after the injection with no adverse events reported.  No concomitant medications were reported.  No treatment medications were reported.
administration of a Kinrix dose to a 6 month old patient; Inappropriate schedule of vaccine administered; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old male patient who received DTPa-IPV (Kinrix) (batch number 7P5J5, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included DTaP (received DTaP doses on an unknown dates).   On 19th April 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 19th April 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received a dose of Kinrix at the age of 6 months, which led to inappropriate age at vaccine administration. The reporter stated that this would have been the third dose in the series, which led to inappropriate schedule of vaccine administered. The reporter called for information regarding safety and validity of the administration of a Kinrix dose to a 6 month old patient. The reporter confirmed that healthcare professional had given previous DTaP doses to the patient but not Kinrix. Kinrix was administered to the patient for the first time. The reporter consented to follow up.
Pitting edema of bilateral lower extremities below knees  R>L  with compression of feet/toes tingling Lasting > 7 days
I have a small red rash on my right cheek. This started about 8 hours after I received my vaccine. It has been a little itchy but seems to be improving on its own.
Initial unsolicited report received from a patient on 05 August 2015. A male patient (age not reported), whose medical history and concomitant medications were not reported, had received a dose of MENACTRA (batch number, expiry date, route and site of administration were not reported) on an unspecified date. On an unspecified date; after vaccination, the patient presented an adverse event. Laboratory investigations and corrective treatments were not reported. At the time of this report, outcome of event was not reported. Documents held by sender: none.
I had the typical normal reactions of achy arm, fever, headache, body aches and my balance was a little off and basically feeling under the weather. On 3/26/2021, I noticed I was having double vision when I look at a far distance. I woke up on the 3/27/21 and the whole left side of my face was puffy. It was affecting me closing my mouth and causing ear pain. By the time I could see the doctor, it had resolved. I had a CAT scan and did not find anything. I went to see another doctor for my vision issues. My eye doctor corrected my double vision by adding a prism to my glasses.
Severe body aches, severe chills and headaches. Unable to sleep due to pain. Lasted all night and all the following day. 3rd day less severe
VERY QUICKLY AFTER THE PATIENT THE VACCINE SHE HAD REDNESS, LIGHTHEADEDNESS, TINGLING, NAUSEA, SWEATING, CHEST AND NECK TIGHTNESS. HER BREATHING WAS GETTING WORSE INITIALLY BUT GOT BETTER ONCE SHE REMOVED TH MASK. PARAMEDICS CAME, MEASURED HER BLOOD PRESSURE (140/97) AND TOOK HER TO ED
Significant swelling/redness at injection site with a hard lump for 36 hours and counting, fatigue, loss of breath and a fever of 102ºF.
Shivers, fever throughout first night. Treated with ibuprofen. Resolved by morning. Low energy next day
After approximately 12 hours I started feeling aches and pain of body, joints. Also, headache started developing at same time along with mild fever. All symptoms continued for approximately 36-40 hours. Then approximately 40 hours later my lymph glands under my left armpit and in my neck became swollen and painful. Sore throat accompanied this condition.
When pt came home all joints muscle, back started hurting, seamed to keep getting worst after she had gotten some muscle relaxers and pain pills, Day 3 mom couldn't walk and was found on the floor, diff breathing and very week, EMS was called and taken to hospital for 3nights,
Patient is fully vaccinated and died due to COVID related causes. According to patient's wife,  he presented to hospital with sinus problem runny nose and  congestion headache two days before the 8/21 and on 08/21/21 he became Lethargic and had a unsteady Gait prior to testing. Believe contracted Covid from church.  Patient died nine days later.
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Patient presented at pharmacy 8/19/21 after receiving 2nd dose Pfizer Vaccine on 8/16/21.  Patient stated she experienced expected side effects up to 24 hours after vaccination (discomfort at injection site, fatigue, body ache.)  and symptoms resolved.  Approximately 48-72 hours after vaccination, patient developed new arm tenderness that developed into redness, mild swelling and itching.  Recommended oral diphenhydramine with PCP follow-up.
Patient received Pfizer COVID vaccine on 1/22/21 and 2/12/21. On 1/10/22, patient admitted to our inpatient facility with acute kidney injury on CKD 4 -likely progressive worsening of underlying CKD due to noncompliance with medications/appointments, hypertensive urgency in association with the acute worsening of kidney injury, and COVID-19 positive (no respiratory symptoms, not hypoxic).  As of today (1/17/22), patient is still admitted in our med/surg unit.
Light headedness and dizzy within 45 minutes of shot.  Day 2 nerve pain in left shoulder moving to neck and right arm.  Day 3 severe nerve pain in forearms Day 4 some nerve pain in upper legs and arms. Continuing severe nerve pain in forearms for 4-5 days Day 8 symptoms subsided
Headache, muscle ache, joint stiffness and general fatigue.  Noticed starting about noon the second day.  Only headache remained the third day and became better as the day progressed
Pt received 1st dose of Moderna vaccine in am at COVID vaccination clinic.  On presentation to clinic he stated he was feeling well.  Pt was brought to ER in pm with hypoxic, requiring 15L supplemental O2.  Per pt's family, pt was not feeling well for the last couple of days but didn't think it was related to COVID. Abbott COVID + in ER.  Possible vaccine reaction, though seems unlikely.
HYPOTENSION 6/18/2022 -- RECURRENCE OF SAME SYMPTOMS
PATIENT DEVELOPED BRUSING ON FRONT AND BACK OF LEFT SHOULDER. PATIENT REPORTS PAIN THAT TRAVELS DOWN HIS ARM WHEN HE TOUCHES THE ANTERIOR SHOULDER AND REPORTS PAIN WHEN LAYING ON THAT SIDE. PATIENT STATES HE DEVELOPED THE BRUSING AND PAIN ABOUT 1 DAY AFTER THE SHOT WAS GIVEN.
Patient received vaccines beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccines beyond use date after the thaw process) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030h21b) for COVID-19 prophylaxis.     It was unknown whether the patient was diagnosed or tested positive for covid-19.  Acute illness at the time of vaccination and up to one month before was not known.  Chronic and long-standing health conditions were unknown.     On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccines beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccines beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported has 54 years 5 month.  The patient got Moderna with vaccine Ndc code 80777027399.  The medical notified of an audit that was done which made aware that some vaccines were administered beyond use date after the thaw process.  There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  Concomitant drugs were not reported.  Treatment details were not reported.   This case was linked to MOD-2022-542869 (Patient Link).
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications and drug reaction or allergies was reported. On an unknown dates in 2016 (dates ranging from 26-FEB-2016 to 04-MAY-2016), the patients were vaccinated with improperly stored doses of VAQTA injection (dose, route of administration site, lot # and expiry date were not specified). Administered doses of VAQTA underwent temperature excursion at excursion on 25-FEB-2016, with temperature at minimum 30 Fahrenheit degrees and maximum 39 Fahrenheit degrees for less than 12 hours. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
I was brought back only to remain in a coma for 11 days; it attacked my heart; I was paralyzed; I am on dialysis kidneys no longer function; 190 pounds of muscle when I left the hospital I was 150 pounds; This is a spontaneous report from a contactable consumer (patient). An unspecified age and gender patient received the first dose of BNT162B2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. The patient stated: "I took the first Covid vaccine shot and it attacked heart. It killed me and I was brought back only to remain in a coma for 11 days when I woke from my coma I was  paralyzed from the waste down and had to do physical therapy to walk again. I am on dialysis cause my kidneys no longer function. Before the shot I worked out six days a week and was 190 pounds of muscle when I left the hospital I was 150 pounds of skin and bones. Now I have huge medical bills due to a shot". The outcome of coma was recovered in 2021. The outcome of other events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Chills; Muscle aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Muscle aches) and HEADACHE (Headache) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Muscle aches) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), MYALGIA (Muscle aches) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Pain in left side of jaw. Pain lasted for @ 1/2 day. Resolved without treatment.
Pain in both eyes above the eye lids; having trouble breathing; body aches/left side hurts from my head to my big toe; obstruction in my throat; headache; This spontaneous case was reported by a consumer and describes the occurrence of EYELID PAIN (Pain in both eyes above the eye lids), DYSPNOEA (having trouble breathing), PAIN (body aches/left side hurts from my head to my big toe), THROAT TIGHTNESS (obstruction in my throat) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYELID PAIN (Pain in both eyes above the eye lids), DYSPNOEA (having trouble breathing), PAIN (body aches/left side hurts from my head to my big toe), THROAT TIGHTNESS (obstruction in my throat) and HEADACHE (headache). At the time of the report, EYELID PAIN (Pain in both eyes above the eye lids), DYSPNOEA (having trouble breathing), PAIN (body aches/left side hurts from my head to my big toe), THROAT TIGHTNESS (obstruction in my throat) and HEADACHE (headache) outcome was unknown.            Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Patient developed mild case of measles with distinct morbilliform rash, cough, coryza and high fever
When the appointment was booked, the father accidentally booked her for a second dose appointment, instead of a bivalent booster. She was meant to have the bivalent booster. At the site this was not communicated, and the patient received a primary series dose instead of the bivalent booster. There were no physical adverse events caused by the dose given.